Telo Genomics Corp. funding
Telo Genomics Corp., a biotechnology company based in Vancouver, British Columbia, Canada, filed a Form D with the SEC on April 24, 2026 and reported $7.3K raised of a $19.1K offering.
Amount raised$7.3K
Offering size$19.1K
Filed with the SECApril 24, 2026
First saleMarch 6, 2026
IndustryBiotechnology
SecuritiesEquity, Debt, Options or warrants, Security to be acquired on exercise, Other
LocationVancouver, British Columbia, Canada
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 24
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology